TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$16.93
+0.01 (+0.06%)
Open$16.92
Previous Close$16.92
Day High$16.95
Day Low$16.91
52W High$21.03
52W Low$11.05
Volume—
Avg Volume404.8K
Market Cap876.93M
P/E Ratio7.66
EPS$2.20
SectorPharmaceuticals
Analyst Ratings
Hold
11 analysts
Price Target
+47.4% upside
Current
$16.93
$16.93
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 108.26M | 84.61M | 591.55M |
| Net Income | 106.68M | 75.04M | 75.68M |
| Profit Margin | 98.5% | 93.6% | 12.8% |
| EBITDA | 48.38M | 35.92M | 125.32M |
| Free Cash Flow | — | — | 94.80M |
| Rev Growth | +28.0% | +28.0% | +8.8% |
| Debt/Equity | 0.11 | 0.11 | 1.02 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |